TransCode Therapeutics, Inc. (RNAZ)

NASDAQ: RNAZ · IEX Real-Time Price · USD
0.642
-0.037 (-5.39%)
Mar 28, 2024, 12:14 PM EDT - Market open

Total Valuation

RNAZ has a market cap or net worth of $717,169. The enterprise value is -$6.14 million.

Market Cap 717,169
Enterprise Value -6.14M

Important Dates

The next estimated earnings date is Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

RNAZ has 6.57 million shares outstanding. The number of shares has increased by 386.56% in one year.

Shares Outstanding 6.57M
Shares Change (YoY) +386.56%
Shares Change (QoQ) +139.27%
Owned by Insiders (%) 1.35%
Owned by Institutions (%) 2.99%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.16
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.13.

Current Ratio 1.67
Quick Ratio n/a
Debt / Equity 0.13
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -821.80% and return on invested capital (ROIC) is -414.87%.

Return on Equity (ROE) -821.80%
Return on Assets (ROA) -267.60%
Return on Capital (ROIC) -414.87%
Revenue Per Employee n/a
Profits Per Employee -$1.03M
Employee Count 19
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -99.74% in the last 52 weeks. The beta is -0.38, so RNAZ's price volatility has been lower than the market average.

Beta (1Y) -0.38
52-Week Price Change -99.74%
50-Day Moving Average 0.70
200-Day Moving Average 32.37
Relative Strength Index (RSI) 32.91
Average Volume (30 Days) 659,481

Short Selling Information

The latest short interest is 174,746, so 2.66% of the outstanding shares have been sold short.

Short Interest 174,746
Short Previous Month 101,999
Short % of Shares Out 2.66%
Short % of Float n/a
Short Ratio (days to cover) 0.10

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -20.89M
Pretax Income -19.59M
Net Income -19.59M
EBITDA -19.19M
EBIT -19.59M
Earnings Per Share (EPS) -$774.80
Full Income Statement

Balance Sheet

The company has $7.45 million in cash and $594,694 in debt, giving a net cash position of $6.86 million or $1.04 per share.

Cash & Cash Equivalents 7.45M
Total Debt 594,694
Net Cash 6.86M
Net Cash Per Share $1.04
Equity / Book Value 4.44M
Book Value Per Share 0.68
Working Capital 3.78M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.43 million and capital expenditures -$63,824, giving a free cash flow of -$16.49 million.

Operating Cash Flow -16.43M
Capital Expenditures -63,824
Free Cash Flow -16.49M
FCF Per Share -$208.98
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RNAZ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -386.56%
Shareholder Yield -386.56%
Earnings Yield -2,731.94%
FCF Yield -2,299.96%

Analyst Forecast

The average price target for RNAZ is $120.00, which is 18,582.86% higher than the current price. The consensus rating is "Strong Buy".

Price Target $120.00
Price Target Difference 18,582.86%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -74.66%
Stock Forecasts

Stock Splits

The last stock split was on January 16, 2024. It was a reverse split with a ratio of 1:40.

Last Split Date Jan 16, 2024
Split Type Reverse
Split Ratio 1:40

Scores

Altman Z-Score n/a
Piotroski F-Score 1